Cargando…
Health benefit and economic impact of utilising ECMO in COVID-19 patients: patient or cost first
Autores principales: | Butt, Sundas, Shankar, Meera, Amien, Bothayna, Fedevici, Oleg, Harky, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929785/ https://www.ncbi.nlm.nih.gov/pubmed/36819563 http://dx.doi.org/10.21037/atm-22-6391 |
Ejemplares similares
-
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?
por: Alom, Samiha, et al.
Publicado: (2021) -
The role of ECMO in COVID‐19: Can it provide rescue therapy in those who are critically ill?
por: Savarimuthu, Sugeevan, et al.
Publicado: (2020) -
Do ECMO First Even in the Desperate Situation
por: Heo, Jung Ho
Publicado: (2021) -
COVID-19 and Multiorgan Response: The Long-Term Impact
por: Harky, Amer, et al.
Publicado: (2023) -
Predicting clinical outcome in patients undergoing VA-ECMO
por: Kimmoun, Antoine, et al.
Publicado: (2019)